Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2019-09-16 Report Publication Anno…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Korrektion: Sammenfatning af kapitalnedsættelse, jf. kapitalmarkedslovens §32
Report Publication Announcement Classification · 95% confidence The document is very short (477 characters) and functions as a landing page or notification for an attached file titled '2019_35_Corretion_Summary_of_capital_reduction_DK'. It directs the user to download the actual report. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2019-09-16 English
Correction: Summary of capital reduction pursuant to Article 32 of the Danish Capital Markets Act
Net Asset Value Classification · 99% confidence The document text is extremely short (476 characters) and primarily consists of a link to an attachment titled '2019_35_Correction_Summary_of_capital_reduction_EN' and a prompt to 'Please read the full announcement here'. This structure strongly suggests that the document itself is merely an announcement pointing to the substantive filing. The content relates to a 'capital reduction', which falls under capital structure changes. However, based on the 'MENU VS MEAL' rule, since this is an announcement of a document rather than the document itself, and given the context of a regulatory filing platform, the most appropriate classification is Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since 'capital reduction' is a specific corporate action, and RPA is for announcing the publication of reports, RNS is a safer fallback for a general regulatory notice pointing to a specific document, unless the capital reduction announcement itself is considered a specific report type. Given the options, and the nature of pointing to an attachment about a capital reduction, it is a regulatory announcement. If we strictly follow the 'MENU VS MEAL' rule for short documents announcing other content, RPA is plausible if the attachment is considered a 'report'. However, 'capital reduction' is a specific event. Let's re-evaluate the definitions. The attachment title suggests a correction summary related to a capital reduction. This is a specific corporate action announcement. Since there isn't a specific code for 'Capital Reduction Announcement' other than CAP (Capital/Financing Update), and this is clearly an announcement pointing to the details, CAP might be the intended target if the announcement itself is the primary focus, or RNS/RPA if it's just a notice of publication. Given the brevity and the instruction to read the full announcement elsewhere, RPA (Report Publication Announcement) fits the pattern of announcing the availability of the detailed information. If the content was the actual summary, CAP would be better. Sticking to the announcement nature: RPA.
2019-09-16 English
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is titled "Transaktioner i forbindelse med Novozymes' aktietilbagekøbsprogram" (Transactions related to Novozymes' share buyback program) and details the number of shares bought back, the transaction value, and specific daily trade data (dates, prices, volumes, exchanges). This content directly relates to the company repurchasing its own shares. According to the definitions, this corresponds to the 'Transaction in Own Shares' category. Code: POS (Transaction in Own Shares). The document is a detailed report/announcement of these transactions, not just an announcement that a report is forthcoming (which would be RPA or RNS). The length is substantial (over 116k characters, though truncated), suggesting it is the primary disclosure of the activity.
2019-09-16 English
Transaction in Own Shares 2019
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (401 characters) and explicitly states, "Please read the full announcement in the attached PDF" and provides a link to a document titled "Transactions under Novozymes’ stock buyback program". This structure—a brief announcement pointing to a full document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), according to the 'MENU VS MEAL' rule. Since the content specifically relates to the company buying back its own shares, the most precise category is Transaction in Own Shares (POS). However, because this document is merely an announcement *about* the transaction report (and not the detailed report itself), and given the short length and instruction to read the attachment, it aligns best with RPA (Report Publication Announcement) or RNS. Given the specific nature of the underlying topic (stock buyback), and the fact that POS documents often contain the details, classifying this brief notice as RPA is appropriate as it announces the publication of the details. If the content were the detailed transaction log, POS would be correct. Since it's just the announcement, RPA is the best fit among the announcement types, although RNS is a possibility if RPA is too specific. Given the options, RPA is chosen as it announces the publication of a specific report/update.
2019-09-16 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a short announcement (427 characters) regarding transactions in Novozymes' share buyback program. It explicitly directs the reader to an attached file for the full details. According to the 'Menu vs Meal' rule, an announcement of a report or transaction details that directs the user to an attachment is classified as a Report Publication Announcement (RPA).
2019-09-16 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a company announcement detailing transactions under Novozymes' stock buyback program, including the number of shares purchased, transaction values, and detailed trading data. It references a specific stock buyback program initiated in 2019 and provides extensive transactional data but does not contain financial statements, earnings data, or management discussion. The content is focused on the company's repurchase of its own shares, which aligns with the category for reports on share repurchases or issuances by the company itself. Therefore, the document fits the category 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed transactional data, confirming it is not a mere announcement of a report but the actual transactional disclosure.
2019-09-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.